Related Experiment Video
Updated: Mar 1, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection
Michał Kosowski1, Piotr Kübler, Adam Kołodziej
1Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland, Poland; Department of Cardiology, Centre for Heart Diseases, Clinical Military Hospital, Wroclaw, Poland, Poland. mkosowski@gmail.com.
Abstract:
Heart failure with preserved ejection fraction (HFpEF) is a condition with complex pathophysiology and clinical profile. No treatment has been proven to reduce mortality or reduce morbidity in a meaningful way. In the era of percutaneous cardiac interventions, a novel method of reducing left atrial pressure by creating an iatrogenic interatrial shunt has been introduced. We present a report of implantation of InterAtrial Shunt Device (IASD®) in three consecutive patients.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Heart Failure V: Medical Management

